MADISON, N.J., Aug. 12, 2011 /PRNewswire/ — Quest
Diagnostics Incorporated (NYSE:
DGX), the world’s leading provider of diagnostic testing,
information and services, today announced that its Board of
Directors declared a quarterly cash dividend of $0.10 per share,
payable on October 24, 2011, to shareholders of record of
Quest Diagnostics common stock on October 7, 2011.
About Quest Diagnostics
Quest Diagnostics is the world’s leading provider of diagnostic
testing, information and services that patients and doctors need to
make better healthcare decisions. The company offers the broadest
access to diagnostic testing services through its network of
laboratories and patient service centers, and provides interpretive
consultation through its extensive medical and scientific staff.
Quest Diagnostics is a pioneer in developing innovative new
diagnostic tests and advanced healthcare information technology
solutions that help improve patient care. Additional company
information is available at QuestDiagnostics.com.
Follow us at Facebook.com/QuestDiagnostics
Quest Diagnostics Contacts:
Kathleen Valentine (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800